Moleculin Biotech, Inc. (MBRX)
Total Valuation
MBRX has a market cap or net worth of $12.30 million. The enterprise value is -$10.78 million.
Market Cap | 12.30M |
Enterprise Value | -10.78M |
Important Dates
The last earnings date was Friday, March 22, 2024, after market close.
Earnings Date | Mar 22, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
MBRX has 2.23 million shares outstanding. The number of shares has increased by 3.60% in one year.
Shares Outstanding | 2.23M |
Shares Change (YoY) | +3.60% |
Shares Change (QoQ) | +1.57% |
Owned by Insiders (%) | 4.65% |
Owned by Institutions (%) | 15.54% |
Float | 1.93M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | n/a |
Forward PS | n/a |
PB Ratio | 0.47 |
P/FCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.86, with a Debt / Equity ratio of 0.02.
Current Ratio | 3.86 |
Quick Ratio | n/a |
Debt / Equity | 0.02 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -80.90% and return on invested capital (ROIC) is -111.62%.
Return on Equity (ROE) | -80.90% |
Return on Assets (ROA) | -67.70% |
Return on Capital (ROIC) | -111.62% |
Revenue Per Employee | n/a |
Profits Per Employee | -$1.98M |
Employee Count | 15 |
Asset Turnover | n/a |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -61.65% in the last 52 weeks. The beta is 1.98, so MBRX's price volatility has been higher than the market average.
Beta (1Y) | 1.98 |
52-Week Price Change | -61.65% |
50-Day Moving Average | 7.92 |
200-Day Moving Average | 8.40 |
Relative Strength Index (RSI) | 35.11 |
Average Volume (30 Days) | 29,471 |
Short Selling Information
The latest short interest is 31,259, so 1.40% of the outstanding shares have been sold short.
Short Interest | 31,259 |
Short Previous Month | 134,431 |
Short % of Shares Out | 1.40% |
Short % of Float | 1.62% |
Short Ratio (days to cover) | 1.51 |
Income Statement
Revenue | n/a |
Gross Profit | n/a |
Operating Income | -29.63M |
Pretax Income | -29.77M |
Net Income | -29.77M |
EBITDA | -29.64M |
EBIT | -29.77M |
Earnings Per Share (EPS) | -$15.07 |
Balance Sheet
The company has $23.55 million in cash and $474,000 in debt, giving a net cash position of $23.08 million or $10.36 per share.
Cash & Cash Equivalents | 23.55M |
Total Debt | 474,000 |
Net Cash | 23.08M |
Net Cash Per Share | $10.36 |
Equity / Book Value | 26.07M |
Book Value Per Share | 11.71 |
Working Capital | 19.46M |
Cash Flow
In the last 12 months, operating cash flow was -$24.10 million and capital expenditures -$124,000, giving a free cash flow of -$24.23 million.
Operating Cash Flow | -24.10M |
Capital Expenditures | -124,000 |
Free Cash Flow | -24.23M |
FCF Per Share | -$12.26 |
Margins
Gross Margin | n/a |
Operating Margin | n/a |
Pretax Margin | n/a |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
MBRX does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.60% |
Shareholder Yield | -3.60% |
Earnings Yield | -242.11% |
FCF Yield | -197.02% |
Analyst Forecast
The average price target for MBRX is $101.67, which is 1,735.20% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $101.67 |
Price Target Difference | 1,735.20% |
Analyst Consensus | Strong Buy |
Analyst Count | 3 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on February 1, 2021. It was a reverse split with a ratio of 1:6.
Last Split Date | Feb 1, 2021 |
Split Type | Reverse |
Split Ratio | 1:6 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | 1 |